Details for New Drug Application (NDA): 080925
✉ Email this page to a colleague
NDA 080925 describes ISOCAINE HYDROCHLORIDE, which is a drug marketed by Septodont and is included in two NDAs. Additional details are available on the ISOCAINE HYDROCHLORIDE profile page.
The generic ingredient in ISOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
The generic ingredient in ISOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 080925
| Tradename: | ISOCAINE HYDROCHLORIDE |
| Applicant: | Septodont |
| Ingredient: | mepivacaine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080925
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
